Prm167 - Mapping the Sf-36 to Eq-5d-3l in Randomized Trial: The Emocar Study (May 2011 – April 2016)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mapping From SF-36 Trial Data to EQ-5D Utilities in Advanced Basal Cell Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

A Comparison of the EQ-5D-3L and EQ-5D-5L

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2020English

Mapping the Beck Depression Inventory to the Eq-5d-3l in Patients With Depressive Disorders

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pih53 - Comparison of the Eq-5d-5l and the Eq-5d-3l Using Individual Patient Data From Reform Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Measurement Properties of the EQ-5D-5L Compared to EQ-5D-3L in the Thai Diabetes Patients

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2015English

Comparing Responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in Stroke Patients

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2014English

Head-To-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

Ql3 - Eq-5d-5l Is More Responsive Than Eq-5d-3l to Treatment Benefit of Cataract Surgery

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prm180 - Comparing Qalys Generated for the Eq-5d-3l and Eq-5d-5l in a Longitudinal Study of Cancer Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy